Blood pressure medication should be routinely dosed at bedtime. An internist's critical appraisal of the editorial by Rainhold Kreutz et al. (2020). Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. Blood Pressure. 29 (3):135-136

• Published in: Chronobiology international Vol. 37; no. 5; pp. 767 - 770
• Main Author: Machado, António Pedro
• Format: Journal Article
• Language: English
• Published: Taylor & Francis 03.05.2020
• Subjects: Ambulatory blood pressure monitoring; bedtime hypertension chronotherapy; cardiovascular risk; hygia Chronotherapy Trial; hypertension guidelines; hypotension
• ISSN: 0742-0528; 1525-6073
• DOI: 10.1080/07420528.2020.1781358

The history of hypertension the past hundred years is a successful story of the fall of myths, beliefs, and assumptions under the weight of evidence. The recent editorial by Kreutz et al. (2020),"Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project", published in Blood Pressure, conveys unjustified concerns founded on baseless doubts and suspicions about the Hygia Chronotherapy Trial. The physicians of Portugal are beginning to incorporate into routine clinical practice the proven methods of the Hygia Chronotherapy Trial - 48-hour ambulatory blood pressure monitoring and bedtime hypertension chronotherapy - to improve in a cost-effective matter the diagnosis and management of hypertension and to reduce the overwhelming burden of cardiovascular morbidity and mortality in our country.